ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2020
Late complications associated with totally implantable venous access port implantation via the internal jugular vein.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.
- [Clinical Practice and Quality Control Guidelines for Totally Implantable Venous Access Ports in Cancer Patients (2024)].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025Guideline
- Meta-analysis of primary open versus closed cannulation strategy for totally implantable venous access port implantation.Langenbeck's archives of surgery · 2021Pooled it
- Transverse versus longitudinal skin incisions for totally implantable venous access port implantation: a randomized controlled trial.Langenbeck's archives of surgery · 2026Trial
- Research progress and narrative review of totally implantable venous access ports.Frontiers in oncology · 2026Review
- Is there a difference in catheter-related thrombosis between left- and right-sided arm ports and chest ports?Frontiers in surgery · 2026Review
- Rare advanced complication of an infusion port with pocket skin necrosis successfully preserve the port : a case report.Journal of cardiothoracic surgery · 2025Article
- Skin and soft tissue disorders caused by trabectedin extravasation: A case report.Biomedical reports · 2025Article
- A simple calculation formula for the insertion depth of catheter of the central venous access port in Chinese patients.Heliyon · 2024Article
- Machine learning risk prediction model for bloodstream infections related to totally implantable venous access ports in patients with cancer.Asia-Pacific journal of oncology nursing · 2024Article
- Predictive model for totally implanted venous access ports‑related long‑term complications in patients with lung cancer.Oncology letters · 2024Article
- Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review.BMC cancer · 2024Article
- Migration of silicone catheter into pleural space: a case report.Oxford medical case reports · 2023Article
- Safety of Early Bevacizumab Administration after Central Venous Port Placement for Patients with Colorectal Cancer.Cancers · 2023Article
- Article
- Contrast examination of central venous access port implanted through internal jugular vein for evaluation of suspected complications.Japanese journal of radiology · 2021Article
- Perioperative and Postoperative Complications of Supraclavicular, Ultrasound-Guided, Totally Implantable Venous Access Port via the Brachiocephalic Vein in Adult Patients: A Retrospective Multicentre Study.Therapeutics and clinical risk management · 2021Article
- Intraoperative ipsilateral subclavian port catheter implantation in resectable breast cancer patients: A novel, safe, and convenient clinical practice.Cancer medicine · 2020Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeSeveral studies have analyzed late complications associated with totally implantable venous access ports (TIVAP) implantation via the internal jugular vein (IJV); however, the reported results are inconclusive. The aim of the study is to elucidate the characteristics and risk factors of late complications associated with TIVAP implantation via the IJV.
methodsThe study included 482 patients who underwent TIVAP implantation for long-term chemotherapy and/or nutritional support between April 2012 and December 2017. Most patients (95.2%) had malignant diseases. Events requiring TIVAP removal were defined as TIVAP-related complications.
resultsThe median TIVAP and global follow-ups were 319 days (IQR 152-661) and 218,971 catheter days, respectively. The 3-year cumulative TIVAP availability rate was 70%. There were 44 complications (incidence of 9.1%; 0.201 complications/1000 catheter days). Infectious, catheter-related, and port-related complications occurred in 21, 14, and 9 patients, respectively with infectious complications occurring earlier and more frequently than catheter- and port-related complications. Multivariate analysis revealed that age < 65 years and presence of non-gastrointestinal diseases were significant unfavorable factors for TIVAP-related complications. Patients with 1 and 2 of these factors had an elevated risk (2.2 and 5.4 times, respectively) compared with those without.
conclusionsAmong the late complications associated with TIVAP implantation via the IJV, infectious complications occur earlier and more frequently than catheter- and port-related complications. Patients with an age < 65 years and having non-gastrointestinal diseases have a significantly high risk of TIVAP-related complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.